“The wise man knows that he is ignorant.”
--Socrates, 469 – 399 B.C.

~~~~~~~~~~~~~~~~~~~~~~~~~~

Did you know that the FDA approved Botox ONLY for use on the vertical frown lines between the eyebrows on the bridge of the nose?  (We call them "Worry Lines")

Did you know that light therapeutic lenses may relax facial muscles and many have reported the disappearance of 'worry lines' with their use? 

~~~~~~~~~~~~~~~~~~~~~~~

We came across this unusual letter which we post not as an attack on anyone but rather as a commentary on today's health care world's legal concerns. Notice how the health institution appears to be the bad guy but then the writter states that 'sadly they are right!'.  Also note how he can only tell a patient about alternatives if 'asked' especially if asked what he would do personally if he had that same illness and wanted to treat himself. 

Dear Dr. Mercola,

Your last newsletter discussed "trust." I'm there on the front lines, providing primary care in an urgent 
care setting since 1977. In addition to being a licensed health care professional, I've been a serious
student of alternative and complementary medicine since 1980’s.
A few years back I saw a gentleman in the clinic with diabetic neuropathy who had no feeling at all 
below either of his ankles. His feet were OK, free of ulcers or infection. He was on the usual blend of
mainstream medications which were not helping.
I'd known him for years, so I suggested that he try two supplements:
* Alpha Lipoic Acid: Standard of care therapy for neuropathy in Europe. In fact, in Germany, it's 
malpractice NOT to prescribe Alpha Lipoic Acid for a patient with neuropathy.
* Adaptrin (also available as Padma-Basic): This is an ancient blend of 18 herbs which has a 
remarkable effect on the microcirculation. In other words, it works in the capillaries themselves to
improve blood flow and oxygenation. Among its numerous benefits, many neuropathy patients have all
feeling returned to their feet after two weeks on this stuff.
He asked me to write them down, so I did, having every expectation that he would be better in two 
weeks. When he asked his daughter to get these items, she took the list and rushed over to
administration and complained. Next thing you know, I'm defending myself in a professional review
action. I was condemned, in my own handwriting, by the suggestions I'd written down for the
gentleman.
The issue was not the efficacy of the supplements. The committee didn't care whether they worked or 
not. Alpha Lipoic Acid may be the standard in Europe, but it's NOT the standard here. Their concern was
that any deviation from the official mainstream published "standards of care" exposes the facility to
liability. And Dr. Mercola, the sad part is, they're right.
By agreeing to stick with the "standards of care" in the future, they decided not to terminate me. I was 
officially counseled to NEVER discuss that "homeopathic stuff" with any patients. As a result of this
experience, when I'm on the clock, I'm totally mainstream.
The take-home lesson of this experience is this: Trust works both ways. All it takes is one complaint 
from a patient or a family member to shut down an alternative provider. Even praise will do you in. If a
patient tells another doctor, "Boy, that Sambucol really works. I never catch a cold." I'm in trouble
again.
I'm not totally shut down. If a patient ASKS me about some alternative therapy, I will give them an 
honest and well-informed answer. But if you don't ask, I cannot tell. Another suggestion for a patient
is to ask something like, "If you had my illness, what would you personally use to treat yourself."
That I can answer honestly, because I'm not telling you to do anything.
Very few of the 38 percent of American adults that use complementary medicine ever show up here.
The reality is that patients who go to mainstream clinics expect mainstream care. That's just the way
it is. And I have to meet their expectations. The bottom-line is this: When you're a seeing person in
a blind world, it's unwise to rearrange the furniture.
[Name and position withheld by request]

 ~~~~~~~~~~~~~~~~~~~~~~~~~~

Saffron May Save Aging Eyes

March 23, 2010 

By Sylvia Booth Hubbard


Australian researchers call saffron "nature's sunglasses" and say the aromatic spice "may hold the key to preventing the loss of sight in the elderly."

They discovered that saffron, which is often used in curries and Mediterranean dishes, helps shield the eyes from damages caused by bright sunlight, and may reverse age-related macular degeneration (AMD), the most common cause of blindness in the elderly.

Saffron, which lends food a characteristic yellow color, has long been used in folk medicine. This is the first time, however, its effects on AMD have been explored. AMD typically occurs in older adults, and causes a loss of vision in the middle of the visual field due to damage to the retina. Although peripheral sight is not affected, many sufferers are classified as blind due to the loss of central vision.

Using saffron in pill form, the researchers carried out the study in Italy, where saffron is widely grown. One group of elderly people with AMD took a daily saffron pill for three months, followed by a placebo for three months. A second group took the placebo for three months, followed by the actual saffron pill for three months. In all, 25 subjects participated.

"Patients' vision improved after taking the saffron pill," study leader Professor Silvia Bisti of the University of Sydney said in a statement. "When they were tested with traditional eye charts, a number of them could read one or two lines smaller than before, while others reported they could read newspapers and books again."

Researchers attributed the improvement directly to the saffron. "All patients experienced improvements in their vision while taking the saffron pill," Bisti said. "But when they stopped taking it, the effect quickly disappeared." She believes saffron may regulate the fatty acid content of vision cells, making them "tougher and more resilient."

The Telegraph online reported that the researchers in Australia and Italy are now engaged in a year-long trial to find out more about how the spice works and the best dosage.

According to the National Eye Institute, age-related macular degeneration affects more than 1.75 million people in the U.S. By the year 2020, this number will increase to almost 3 million because of the aging of the American population.

© 2010 Newsmax. All rights reserved.

http://www.newsmaxhealth.com/headline_health/saffron_eye_AMD_/2010/03/23/313829.html?s=al&promo_code=9A0E-1